The expression of TGFβ and PD-L1 by HSCs and HSC-derived cancer-associated fibroblasts (CAFs) may downregulate T-cell-mediated immune responses and increase regulatory T cells [236, 251, 252, 281–283]. The gene discussed is CD274; the disease is cancer.